Quantitative cancer-immunity cycle modeling to optimize bevacizumab and atezolizumab combination therapy for advanced renal cell carcinoma

Documenti analoghi

• A stochastic agent-based model for simulating tumor-immune dynamics and evaluating therapeutic strategies
  di: Zhang, Yuhong, et al.
  Pubblicazione: (2025)
• Spatial information allows inference of the prevalence of direct cell-to-cell viral infection
  di: Williams, Thomas, et al.
  Pubblicazione: (2023)
• A machine learning approach to using Quality-of-Life patient scores in guiding prostate radiation therapy dosing
  di: Yang, Zhijian, et al.
  Pubblicazione: (2020)
• Modeling cell differentiation in neuroblastoma: insights into development, malignancy, and treatment relapse
  di: Martina-Perez, Simon F., et al.
  Pubblicazione: (2025)
• Multilineage-differentiating stress-enduring cells alleviate neuropathic pain in mice by secreting TGF-b and IL-10
  di: Zhao, Yayu, et al.
  Pubblicazione: (2025)